Ye Liu is the founder of Ocumension Therapeutics. Ocumension Therapeutics has raised $200M in total funding. Latest round: IPO. Based in Suzhou, China.
Ye Liu is the CEO and co-founder of Ocumension Therapeutics, an ophthalmology-focused biopharmaceutical company in China. The company was launched in 2018 with an initial investment of USD 5 million from 6 Dimensions Capital. Under his leadership, Ocumension has grown to be a leader in China's ophthalmology drug development. Prior to founding Ocumension, Liu was the Head of Santen China.
Full founder directory · Investor directory · Company funding database · Fundraising library